Alinity ci series instruments for clinical chemistry and immunoassay diagnostics were designed to help labs address modern diagnostic sector challenges—including aging populations, increased incidence of chronic diseases under management, and increased access to care—that are driving increases in testing volume.
Read More
Vantari Genetics and Translational Software have partnered to provide genotype testing, actionable genomic information, and custom reporting in support of the GeneMatch registry at Banner Alzheimer’s Institute.
Read More
Quest Diagnostics has approved a definitive agreement to acquire Cleveland HeartLab, with the intent of establishing a national center of excellence in heart disease diagnostic information services.
Read More
Qiagen and Centogene have entered into a collaboration and comarketing agreement to provide more-complete research and clinical testing solutions for rare genetic diseases.
Read More
In proof-of-concept testing, NRGene’s GenoMagic system provided a complete analysis of a family’s genomic profile based on low-coverage whole-genome sequencing information.
Read More